Manulife Financial Reaffirms 18% Core ROE Goal for 2027, Sees U.S. Mortality Normalizing

The company said the losses were linked to its focus on the high end of the market and “some big deaths,” with policyholders underwritten 10, 15, or 20 years ago. Management described Q2 as “the blip,” while characterizing Q3 and Q4 as closer to normal variability. The company said it does not expect the 2025 mortality experience to persist and highlighted efforts aimed at improving policyholder health through a “Vitality” or behavioral insurance scheme , including proactively offering cancer detection or h ...